End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 SGD | +10.00% | -8.33% | -15.38% |
04-16 | Singapore Shares Fall on Middle East Tensions; Medi Lifestyle Down 8% | MT |
04-16 | Medi Lifestyle Set for Business Diversification | MT |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 20.88 | 68.8 | 57.01 | 35.91 | 15.62 | 5.182 |
Enterprise Value (EV) 1 | 22.73 | 81.22 | 64.12 | 39.03 | 18.52 | 8.793 |
P/E ratio | -1.22 x | 119 x | -20.3 x | -1.39 x | -3.48 x | -0.55 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.05 x | 7.04 x | 91.6 x | 25.7 x | 6.51 x | 2.67 x |
EV / Revenue | 7.68 x | 8.32 x | 103 x | 27.9 x | 7.71 x | 4.53 x |
EV / EBITDA | -3.23 x | -11 x | -6.64 x | -7.42 x | -3.26 x | -1.4 x |
EV / FCF | 5.17 x | -16.2 x | -9.73 x | -14 x | -17.2 x | -1.84 x |
FCF Yield | 19.3% | -6.18% | -10.3% | -7.13% | -5.8% | -54.5% |
Price to Book | -2.05 x | 20 x | 7.49 x | -6.06 x | -1.79 x | -0.56 x |
Nbr of stocks (in thousands) | 28,551 | 41,167 | 49,288 | 55,277 | 59,702 | 114,634 |
Reference price 2 | 0.7312 | 1.671 | 1.157 | 0.6496 | 0.2617 | 0.0452 |
Announcement Date | 19-04-11 | 20-05-15 | 21-04-04 | 22-05-11 | 23-04-12 | 24-04-14 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 2.961 | 9.768 | 0.6227 | 1.397 | 2.401 | 1.943 |
EBITDA 1 | -7.045 | -7.377 | -9.66 | -5.263 | -5.689 | -6.263 |
EBIT 1 | -8.092 | -8.053 | -9.691 | -5.348 | -5.742 | -6.348 |
Operating Margin | -273.25% | -82.44% | -1,556.23% | -382.72% | -239.17% | -326.72% |
Earnings before Tax (EBT) 1 | -8.642 | -10.17 | -10.47 | -13.63 | -4.331 | -7.191 |
Net income 1 | -17.05 | 0.4875 | -2.763 | -23.72 | -4.303 | -7.195 |
Net margin | -575.81% | 4.99% | -443.78% | -1,697.65% | -179.21% | -370.28% |
EPS 2 | -0.5973 | 0.0140 | -0.0570 | -0.4680 | -0.0751 | -0.0829 |
Free Cash Flow 1 | 4.395 | -5.023 | -6.591 | -2.784 | -1.074 | -4.789 |
FCF margin | 148.42% | -51.43% | -1,058.4% | -199.22% | -44.74% | -246.46% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-11 | 20-05-15 | 21-04-04 | 22-05-11 | 23-04-12 | 24-04-14 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.86 | 12.4 | 7.11 | 3.12 | 2.89 | 3.61 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -0.2638 x | -1.683 x | -0.7363 x | -0.5924 x | -0.5087 x | -0.5765 x |
Free Cash Flow 1 | 4.4 | -5.02 | -6.59 | -2.78 | -1.07 | -4.79 |
ROE (net income / shareholders' equity) | 370% | 299% | -190% | -1,628% | 58.8% | 80.2% |
ROA (Net income/ Total Assets) | -13.3% | -18.5% | -23.6% | -26.8% | -116% | -266% |
Assets 1 | 127.9 | -2.642 | 11.7 | 88.62 | 3.72 | 2.709 |
Book Value Per Share 2 | -0.3600 | 0.0800 | 0.1500 | -0.1100 | -0.1500 | -0.0800 |
Cash Flow per Share 2 | 0.0400 | 0.0700 | 0.0100 | 0.0200 | 0.0100 | 0 |
Capex 1 | 0.87 | 0.07 | 0.31 | 0.2 | 0.19 | 0.02 |
Capex / Sales | 29.27% | 0.68% | 49.49% | 14.14% | 7.96% | 1.28% |
Announcement Date | 19-04-11 | 20-05-15 | 21-04-04 | 22-05-11 | 23-04-12 | 24-04-14 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+13.70% | 80.61B | |
-29.20% | 70.18B | |
+9.86% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- Z4D Stock
- 5TN Stock
- Financials MEDI LIFE